ADMA CIK: 1368514

ADMA Biologics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−112
FY22:
−59.5
FY23:
8.80
FY24:
119
FY25:
50.4
Change from FY21 to FY25
millions USD
FY21:
−13.5
FY22:
−13.9
FY23:
−4.98
FY24:
−8.58
FY25:
−21.9
Change from FY21 to FY25
millions USD
FY21:
121
FY22:
109
FY23:
−39.0
FY24:
−58.3
FY25:
−44.0
millions USD
FY21:
−4.83
FY22:
35.4
FY23:
−35.2
FY24:
51.8
FY25:
−15.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−73.4
FY23:
4.03
FY24:
110
FY25:
27.8

All amounts in millions USD Data source:SEC EDGAR